Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Are Corporate Executives Giving Away Good Trading Opportunities With These Insider Purchases?

We can now move on to FelCor Lodging Trust Incorporated (NYSE:FCH), which has seen its stock suffer a loss of almost 26% year-to-date. Richard A. Smith, President and CEO of FelCor, purchased 50,000 shares at $8.05 apiece on Thursday. Following the completion of the transaction, the executive currently owns 1.72 million shares. It is also worth noting that the following transaction represents the first insider buy at FelCor Lodging Trust Incorporated (NYSE:FCH) this year, which could suggest a strong future outlook for the real estate investment trust (REIT). A little more than a month ago, FelCor sold its 288-room airport-area hotel, Holiday Inn, to Sarona Orlando Lee LLC, which is a subsidiary of JHM Hotels, for $14 million. This sale surely improved the REIT’s financial position, which might in turn allow it to acquire new properties. Israel Englander’s Millennium Management boosted its stake in FelCor by 117% during the second quarter to 1.14 million shares.

Last but not least, Select Medical Holdings Corporation (NYSE:SEM)’s director, William H. Frist, bought 8,100 shares at a price of $12.32 each, boosting his stake to 164,334 shares. The company that operates specialty hospital and outpatient rehabilitation clinics in the United States had a great first half of the year, but its shares have embarked on a steady downtrend since the end of June, dropping over 15% year-to-date in the process. Even though this acquisition is not likely to put an end to the downtrend right away, it might suggest the director’s confidence in the company’s growth from current levels. A few weeks ago, Select Medical revealed its financial results for the second quarter, which did not allow the stock to achieve a turnaround. The company reported net operating revenues of $887.1 million, up by 14.8% year-over-year, while the company’s fully diluted income per share came to $0.28, compared with $0.27 reported a year ago. Finally, Select Medical expects its consolidated net operating revenues for the full year to be in the range of $3.68 billion to $3.75 billion. From the 737 hedge funds tracked by Insider Monkey, Conan Laughlin’s North Tide Capital is the most bullish on Select Medical Holdings Corporation (NYSE:SEM), holding 13.0 million shares.

Disclosure: None

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.